Improvement of depression in a patient with hypothyroidism and deiodinase polymorphism with LT3 Therapy

We report a 54‐year‐old man with treatment‐resistant depression (TRD) and hypothyroidism who responded to LT3/LT4 combination, rather than LT4 alone. He was able to discontinue all antidepressant medications eventually. Interestingly, the patient has a DIO2 polymorphism.

Detalles Bibliográficos
Autores principales: Ahmed, Ziyan S., Sherin, Rinsha P. V., Fonseca, Tatiana L., Hoang, Thanh D., Shakir, Mohamed K. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005678/
https://www.ncbi.nlm.nih.gov/pubmed/35432999
http://dx.doi.org/10.1002/ccr3.5651

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005678/
https://www.ncbi.nlm.nih.gov/pubmed/35432999
http://dx.doi.org/10.1002/ccr3.5651

Ejemplares similares